Literature DB >> 1353528

Pheochromocytoma in children: 15 cases.

Y Révillon1, P Daher, D Jan, C Buisson, V Bonnerot, H Martelli, C Nihoul-Fékété.   

Abstract

Pheochromocytoma is an uncommon tumor in childhood; nevertheless, 20% of all pheochromocytomas are found in the pediatric population. Fifteen children have been treated in our institution from 1962 to 1990. One percent of patients referred over the same period for investigation of high blood pressure were found to have a pheochromocytoma. The majority of patients have hypertension. It varies in intensity and is paroxysmal in about half the patients. Many pediatric cases of unilateral, bilateral, extra-adrenal, familial, and recurrent pheochromocytomas have been reported. We reviewed our 28 years experience with this tumor and concentrated on the diagnosis, the preoperative and operative management, and the occurrence of the multiple endocrine neoplasia syndromes.

Entities:  

Mesh:

Year:  1992        PMID: 1353528     DOI: 10.1016/0022-3468(92)90396-o

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Laparoscopic adrenalectomy in children.

Authors:  E Mirallié; M D Leclair; P de Lagausie; D Weil; V Plattner; C Duverne; A DeWint; G Podevin; Y Héloury
Journal:  Surg Endosc       Date:  2001-02       Impact factor: 4.584

2.  Pheochromocytoma surgery: epidemiologic peculiarities in children.

Authors:  Dmitry G Beltsevich; Nikolay S Kuznetsov; Airazat M Kazaryan; Maryana A Lysenko
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

Review 3.  Characteristics of Pediatric Pheochromocytoma/paraganglioma.

Authors:  Vijaya Sarathi
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

Review 4.  Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.

Authors:  Graeme Eisenhofer; Mirko Peitzsch; Nicole Bechmann; Angela Huebner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.